Indofil Industries Ltd Unlisted Shares
₹ 1,435
About Indofil Industries Ltd Unlisted Shares
Are you looking for a value investment in India’s stable agrochemical sector? Indofil Industries Limited is a fully-integrated, multi-product chemical company and a proud part of the prestigious K.K. Modi Group. With a history dating back to 1962, Indofil has evolved into a global player in the manufacturing and marketing of agrochemicals and specialty chemicals.
A Legacy of Excellence:
-
1962: Incorporated as a subsidiary of Rohm and Haas Company, US.
-
2007: Became Indofil Organic Industries Limited.
-
2010: Rechristened as Indofil Industries Limited.
Today, Indofil is known for providing high-quality crop care solutions to farmers, helping them implement best practices in crop protection through strong R&D and a vast distribution network.
Global Quality & Recognition:
Indofil products meet international standards with accreditations like ISO 9001, OHSAS 18001, and ISO 14001. The company holds 8 patents and has invested heavily in innovation, with an R&D investment of ₹45 Crore in FY18-19 alone.
Massive Global Footprint:
-
Present in 96+ Countries
-
100+ Product Brands
-
50% of Revenue comes from International Markets
Subsidiaries Driving Growth:
Indofil has established wholly-owned subsidiaries in key global markets to get closer to customers and enhance service:
-
Indofil Industries (Netherlands) B.V. – Europe
-
Indofil Bangladesh Industries Pvt. Ltd.
-
Indofil Costa Rica S.A.
-
Indofil Industries DO Brasil Ltda – The largest agrochemical market in the world
-
Indofil Philippines, Inc.
Strategic Joint Venture:
To secure its supply chain, Indofil entered a Joint Venture with Shanghai Baijin Group, China, for manufacturing Carbon-Di-Sulphide (CS2). This backward integration ensures uninterrupted raw material supply and saves valuable foreign exchange.
Manufacturing Strength:
-
Thane, Maharashtra: 20,000 TPA
-
Dahej Unit 1, Gujarat: 31,000 TPA
-
Synthesis Plant, Dahej Unit 2: 4,000 TPA
New Capacities Coming Online:
-
EBDC Plant, Dahej: 35,000 TPA
-
Innovative Solution Plant, Dahej: 35,000 TPA
Recent Financial Highlights (FY24):
Despite a challenging market, Indofil has shown remarkable financial discipline and growth:
-
Revenue: Held steady at ₹3,118 Crore (vs ₹3,095 Cr in FY23), with 18% volume growth offset by pricing pressures.
-
International Business Volume: Grew by an impressive 38%, with Brazil surging 65%.
-
Gross Margin: Improved from 37% to 42% due to softening raw material prices.
-
Profit After Tax (PAT): Soared by 45% to ₹332 Crore (from ₹241 Cr in FY23).
-
Cash Flow: Generated a robust ₹426 Cr from operations, a huge turnaround from negative cash flow in FY23.
-
Debt Reduction: Repaid ₹200 Cr in debt, showcasing strong financial health.
-
EPS (Earnings Per Share): Stands at an impressive ₹155.
-
Return on Equity (ROE): Healthy 8.5% .
Valuation – A Hidden Gem?
Currently, Indofil unlisted shares are available at ₹1,375 per share, giving it a market cap of ₹3,100 Cr and a P/E ratio of just 10x.
To put this in perspective:
-
Rallis India (Tata Group) trades at a P/E of 47x.
-
Bharat Rasayan Ltd trades at a P/E of 37x.
-
The median P/E for top 10 listed agrochemical companies is over 40x.
Why is Indofil undervalued?
Two primary factors are currently suppressing the valuation, creating a potential opportunity for value investors:
-
Ongoing Legal Disputes: An internal family matter regarding asset division (including Indofil) between the Modi family members has created uncertainty, impacting investor sentiment.
-
No Immediate IPO Plans: A major exit route for unlisted investors is an IPO. The absence of immediate IPO plans limits liquidity expectations, keeping demand (and price) lower than listed peers.
The Opportunity:
For investors who understand the agrochemical sector and are willing to look past temporary governance overhangs, Indofil offers exposure to a globally diversified, debt-reducing, and profit-growing company at a fraction of the valuation of its listed competitors.
Ready to Add a Chemical Major to Your Portfolio?
Buy Unlisted Shares of Indofil Industries Ltd exclusively through Unlisted Network.
Invest in a company with a 60-year legacy, global operations, and significant growth potential.
Fundamentals
| Indofil Industries Limited Unlisted Shares Price | ₹ 1550 Per Equity Share | Market Cap (in cr.) | ₹ 3559 |
| Lot Size | 25 Shares | P/E Ratio | 7.87 |
| 52 Week High | ₹ 1995 | P/B Ratio | 1.01 |
| 52 Week Low | ₹ 1195 | Debt to Equity | 0.07 |
| Depository | NSDL & CDSL | ROE (%) | 12.92 |
| PAN Number | AABCI4568D | Book Value | 1528.31 |
| ISIN Number | INE071I01016 | Face Value | 10 |
| CIN | U24110MH1993PLC070713 | Total Shares | 22958222 |
| RTA | MAS Services Limited |
Financial
| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 2795 | 3037 | 3069 | 3325 |
| Cost of Material Consumed | 1901 | 1923 | 1697 | 1932 |
| Change in Inventory | -262 | 18 | 137 | -74 |
| Gross Margins | 41.36 | 36.09 | 40.24 | 44.12 |
| Employee Benefit Expenses | 219 | 202 | 219 | 257 |
| Other Expenses | 580 | 514 | 574 | 668 |
| EBITDA | 357 | 380 | 442 | 542 |
| OPM | 12.77 | 12.51 | 14.4 | 16.3 |
| Other Income | 87 | 93 | 108 | 165 |
| Finance Cost | 45 | 46 | 39 | 25.5 |
| D&A | 90 | 87 | 89 | 91.7 |
| EBIT | 267 | 293 | 353 | 450.3 |
| EBIT Margins | 9.55 | 9.65 | 11.5 | 13.54 |
| PBT | 308 | 339 | 422 | 589 |
| PBT Margins | 11.02 | 11.16 | 13.75 | 17.71 |
| Tax | 89 | 97 | 90 | 137 |
| PAT | 219 | 242 | 332 | 452 |
| NPM | 7.84 | 7.97 | 10.82 | 13.59 |
| EPS | 102.82 | 113.62 | 155.87 | 198.86 |
Financial Ratios |
2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 12.77 | 12.51 | 14.4 | 16.3 |
| Net Profit Margin | 7.84 | 7.97 | 10.82 | 13.59 |
| Earning Per Share (Diluted) | 102.82 | 113.62 | 155.87 | 198.86 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 602 | 698 | 687 | 651 |
| CWIP | 119 | 150 | 138 | 140 |
| Investments | 899 | 1464 | 2333 | 4768 |
| Trade Receivables | 785 | 758 | 903 | 1109 |
| Inventory | 641 | 689 | 525 | 584.5 |
| Other Assets | 798 | 373.5 | 571 | 750.5 |
| Total Assets | 3844 | 4132.5 | 5157 | 8003 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 21.3 | 21.3 | 21.3 | 22.73 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | 2199 | 2896 | 3973 | 3476 |
| Borrowings | 679 | 559 | 363 | 237 |
| Trade Payables | 818 | 439 | 477 | 521 |
| Other Liabilities | 126.7 | 217.2 | 322.7 | 3746.27 |
| Total Liabilities | 3844 | 4132.5 | 5157 | 8003 |
| Cash-Flow Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PBT | 296 | 295 | 364 | 589 |
| OPBWC | 390 | 410 | 470 | 575 |
| Change in Receivables | -9 | 26 | -142 | -203 |
| Change in Inventories | -285 | -47 | 164 | -59 |
| Change in Payables | 323 | -371 | 42 | 84 |
| Other Changes | 33 | -2 | -15 | -29 |
| Working Capital Change | 62 | -394 | 49 | -207 |
| Cash Generated From Operations | 452 | 16 | 519 | 368 |
| Tax | -55 | -83 | -93 | -136 |
| Cash Flow From Operations | 397 | -67 | 426 | 232 |
| Purchase of PPE | -73 | -86 | -66 | -79 |
| Sale of PPE | 25 | 1 | 1 | 0.5 |
| Cash Flow From Investment | -15 | 1 | 48 | -12 |
| Borrowing | -86 | -130 | -195 | -128.4 |
| Dividend | -18 | -9 | -21 | -27.28 |
| Equity | 0 | 0 | 0 | 36.27 |
| Others From Financing | -47 | -45 | -41 | -24.59 |
| Cash Flow from Financing | -151 | -184 | -257 | -144 |
| Net Cash Generated | 231 | -250 | 217 | 76 |
| Cash at the Start | 294 | 391 | 140 | 358 |
| Cash at the End | 525 | 141 | 357 | 434 |
